WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effective after the US market opens today, June 30, 2025, as part of the 2025 Russell indexes reconstitution. Annual reconstitution of the Russell indexes captures the 4,000 largest US stocks as of April 30, 2025, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place f ...

Summary of Clover Health Investments (CLOV) and Aviana Healthcare Conference Calls Clover Health Investments (CLOV) Industry Overview - Focus on Medicare Advantage market with a technology-driven approach to healthcare delivery Key Financial Results - Medicare Advantage membership increased by 30% year over year [2] - Total revenues rose by 33% year over year [3] - Adjusted EBITDA surged by 279% year over year [3] - Net income increased by over 300% year over year [3] Core Business Model - Technology-first, AI-driven clinical health plan aimed at improving early disease diagnosis and treatment [3] - Utilizes a machine learning and AI-powered platform that integrates over 100 healthcare data sources [3] - Physicians are empowered with actionable insights at the point of care, leading to earlier diagnoses and better health outcomes [3][4] Clinical Outcomes - Significant reduction in hospitalization rates for congestive heart failure patients using Clover Assistant software: 18% decrease in all-cause hospitalization and 25% decrease in 30-day readmissions [5] - Achieved the highest HEDIS score for plans with over 2,000 members, indicating superior quality of care [6][7] Competitive Positioning - Differentiates from traditional Managed Care Organizations (MCOs) by being clinically focused and enabling earlier diagnosis and treatment [8][9] - No risk delegation in financial results, indicating a pure operational model [9] Growth Strategy - Aiming for 30% member growth in 2025, focusing on areas with high member concentration [11] - Cohort analysis shows a decrease in medical cost ratio (MCR) by 700 basis points from year one to year two, indicating cost efficiency [13] - Plans to expand into additional states and offer software to third-party providers [14] Market Potential - Approximately 35 million people in the Medicare Advantage market, with a shift from HMO to PPO plans [15] - Strong conviction in guidance for continued membership and revenue growth [16] Aviana Healthcare Industry Overview - Leading national provider of home care services, focusing on pediatric, adult, and geriatric care [35] Key Financial Results - Revenue expected to exceed $2.15 billion in 2025, with adjusted EBITDA over $207 million [40] - Achieved a 7.5% revenue CAGR over the last five years [39] Strategic Transformation - Five primary strategic initiatives for 2025: 1. Enhance partnerships with government and preferred payers [42] 2. Identify cost efficiencies and synergies [42] 3. Modernize medical solutions [42] 4. Manage capital structure and produce positive free cash flow [42] 5. Engage leaders and employees to deliver the mission [42] Growth and Expansion - Plans to acquire Thrive Skilled Pediatric Care, expanding footprint to 36 states [38] - Targeting organic growth of 5% to 7%, with potential for 10% growth through acquisitions [52] Financial Health - Consolidated adjusted EBITDA increased by 93.1% year over year [60] - Maintains strong liquidity of over $260 million [61] - Focused on deleveraging and maintaining a balanced capital structure [62] Market Demand - Strong demand for home and community-based care, with a focus on reducing total healthcare costs [44] - Continued advocacy for improved reimbursement rates and Medicaid rate integrity [48] Conclusion - Both Clover Health and Aviana Healthcare are positioned for significant growth in their respective markets, leveraging technology and strategic partnerships to enhance service delivery and financial performance.

Clover Health Investments, Corp. (CLOV) reported breakeven earnings for the first-quarter 2025, narrower than the year-ago period’s loss of 5 cents. The bottom line surpassed the Zacks Consensus Estimate of a loss of 7 cents. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Adjusted earnings per share (EPS) from continuing operations were approximately 5 cents compared with EPS of a cent in the year-ago period.CLOV’s Revenues in DetailClover Health registered revenues of $462.3 milli ...

Financial Data and Key Metrics Changes - The company reported a 30% increase in Medicare Advantage (MA) membership and a 33% growth in total revenue year over year [6][19] - Adjusted EBITDA surged by 279% and adjusted net income increased by 322% year over year [19][23] - Insurance revenue grew by 34% year over year to $457 million, driven by strong enrollment [20][23] - GAAP net loss improved by $18 million year over year to a loss of $1 million [23] Business Line Data and Key Metrics Changes - The company experienced strong performance in its Clover Care Services division, providing personalized in-home care visits to members [11][12] - The utilization costs for Part C and Part D are tracking as expected, indicating effective management of care [10][22] Market Data and Key Metrics Changes - The majority of new member growth occurred in core New Jersey markets, reflecting a strong Clover-assisted network presence [20] - Member retention during the Annual Enrollment Period (AEP) and Open Enrollment Period (OEP) was strong, contributing to overall growth [20] Company Strategy and Development Direction - The company aims to expand the reach of Clover Assistant and enhance personalized care management for members [14][30] - Plans to leverage the four-star rating and recent CMS final rate notice to drive growth and profitability in 2026 and beyond [12][30] - The company is actively pursuing partnerships to expand its Counterpart Health initiative, which is expected to contribute to future growth [15][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year 2025 goals, citing strong enrollment and care utilization levels [7][28] - The company anticipates typical Medicare Advantage seasonality trends, with higher utilization expected in the latter half of the year [24] - Management emphasized the importance of their technology-first care model in adapting to industry changes and improving care management [10][13] Other Important Information - The company successfully repurchased 5 million shares of common stock, reflecting confidence in long-term value [25] - Cash flow used in operating activities was $16 million, impacted by working capital dynamics, but strong cash flow generation is expected for the full year [26] Q&A Session Summary Question: Can you provide any color on how core medical trends are progressing between new versus existing cohorts? - Management indicated that cost trends are as expected, with both new and returning member cohorts trending positively in terms of medical cost ratios and value-based metrics [36] Question: Any updates on the Counterpart Health go-to-market strategy? - Management remains excited about the Counterpart business and plans to provide more updates throughout the year, focusing on improving profitability in the insurance segment [38] Question: How have initial implementations of Counterpart Health gone? - Initial data shows optimism regarding engagement with physicians and early disease diagnosis, with key performance indicators aligning with expectations [42] Question: Has there been any change in the competitive landscape? - Management noted that while competitors are pulling back on benefits and marketing, the company remains focused on its differentiated model and sees opportunities for growth [46][47] Question: Can you break down the building blocks to growth and where the acceleration will come from? - Management highlighted the importance of unit economics from new and returning member cohorts, along with the positive impact of the four-star rating and cost actions taken [51][55]

Clover Health Investments (CLOV) Q1 2025 Earnings Call May 06, 2025 05:00 PM ET Speaker0 Ladies and gentlemen, good afternoon and welcome to the Clover Health First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A question and answer session will follow the prepared remarks. As a reminder, today's call is being recorded. I would now like to turn the call over to Ryan Schmidt, Investor Relations for Clover Health. Please go ahead. Speaker1 Good ...

First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-yearFirst quarter 2025 Total revenues of $462 million, up 33% year-over-yearMedicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’s technology-first care management modelMeaningful improvement across first quarter 2025 profitability metrics: GAAP Net loss of $1 million, as compared to a GAAP Net loss of $19 million a year agoAdjusted EBITDA of $26 million, up 279% year-over-yearAdjuste ...

Core Viewpoint - Clover Health Investments, Corp. announces that Lee A. Shapiro will not seek reelection to the Board of Directors due to new responsibilities as Chairman of the American Heart Association, with his term ending on June 10, 2025 [1][2]. Company Leadership Changes - Lee A. Shapiro has served on Clover Health's Board for four years and has contributed significantly to the company's mission [2]. - Andrew Toy, CEO of Clover Health, expresses gratitude for Shapiro's leadership and insights during his tenure [2]. - Vivek Garipalli, Executive Chairperson and founder, acknowledges Shapiro's unique contributions and announces that Thomas L. Tran will take over as Chairman of the Audit Committee and Nominating and Corporate Governance Committee effective June 10, 2025 [2][3]. Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors [4]. - The company utilizes its software platform, Clover Assistant, to aggregate patient data and improve health outcomes through early identification and management of chronic diseases [4]. - Clover Health offers PPO and HMO Medicare Advantage plans and extends its technology benefits to a broader audience through its subsidiary, Counterpart Health [4].

Core Insights - Clover Health Investments, Corp. will report its first quarter 2025 financial results on May 6, 2025, after market close, followed by a conference call at 5:00 p.m. Eastern Time to discuss the results [1][3] Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company's strategy is driven by its software platform, Clover Assistant, which aggregates patient data to support clinical decision-making and improve health outcomes, particularly in managing chronic diseases [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, emphasizing its flagship wide-network, high-choice PPO plans [2] - Through its subsidiary, Counterpart Health, Clover Health extends its data-driven technology to a broader audience, aiming to enhance patient outcomes and reduce healthcare costs nationwide [2] - The company has published data showcasing the positive impact of its technology on medication adherence and the early identification and management of diabetes and chronic kidney disease [2]

Core Insights - Clover Health has appointed Dr. Shelly Gupta as Chief Medical Officer, bringing over a decade of Medicare Advantage and healthcare leadership experience [1][2] - Dr. Gupta's role will focus on enhancing clinical operations, quality initiatives, and chronic disease management programs, emphasizing patient choice and provider autonomy [1][3] Company Overview - Clover Health is a physician enablement technology company dedicated to improving access to quality healthcare for Medicare beneficiaries, particularly seniors [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes and manage chronic diseases [5] Leadership and Strategy - Dr. Gupta has a proven track record in enhancing clinical outcomes for senior populations, having previously held leadership roles at Humana [2][4] - His expertise in operationalizing clinical innovation aligns with Clover Health's mission to simplify healthcare decisions and empower providers [4] Technology and Innovation - Clover Health's strategy includes leveraging advanced data-driven solutions and innovative technology to optimize Medicare Advantage clinical operations [3][4] - The company aims to enhance care delivery and member satisfaction while advancing value-based care initiatives [3]